Impact of cannabidiol on viability of normal and tumorigenic human kidney cells: are the effects serum-dependent?
Science Letters · 14.04.2023
DOI: 10.48797/sl.2023.29 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Letters, erschienen am 14.04.2023. Verfasst von Sousa und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Cannabidiol (CBD), the main non-psychotropic cannabinoid of Cannabis sativa, has several pharmacological actions with therapeutic potential, including antitumor effects [1]; however, its effect on renal cell carcinoma (RCC) is unknown. Considering that recent research suggests that cell culture conditions, particularly the presence of serum in culture medium, may modulate the cannabinoids' antitumor effects [2], the potential influence of this growth supplement on the response to CBD should be explored.
Objective
To fill this gap, we investigated the sensitivity of human kidney cells to CBD in different growth conditions.
Methods
CBD’s cytotoxic profile was assessed in non-tumoral (HK-2) and tumoral (Caki-1 and 769-P) human renal cell lines, using zero or five percent FBS. The MTT assay was performed at different time-points (24 and 48h) after cells were exposed to a wide range of CBD concentrations (1-100 uM).
Results
CBD induced a concentration-dependent decrease in cell viability across all cell lines and conditions. After 24h at 5% FBS, it was found that HK-2 and Caki-1 cells were the most sensitive to CBD toxicity, followed by 769-P cells (IC50 values were respectively 14.5, 14.8, and 20.0 µM). In a serum-free medium, after 24h, IC50 values markedly decreased (5.2, 7.6, and 6.8 µM for HK-2, Caki-1 and 769-P cells, respectively; p 0.05).
Conclusions
Our findings support that CBD has in vitro anticancer potential against RCC cells, with greater cytotoxic efficacy in the absence of serum. However, CBD cytotoxicity was not selective for tumoral cells, which may be a significant limitation to its safe use in clinical practice. More research is being conducted to investigate the cell death signaling pathways activated by CBD in each cell line.
Schlagwörter
Zitieren
APA
Sousa, D., Amaro, F., Araújo, M., A., Carvalho, & M. (2023). Impact of cannabidiol on viability of normal and tumorigenic human kidney cells: are the effects serum-dependent?. Science Letters. https://doi.org/10.48797/sl.2023.29
Vancouver
Sousa, D., Amaro, F., Araújo, M. A, et al. Impact of cannabidiol on viability of normal and tumorigenic human kidney cells: are the effects serum-dependent?. Science Letters. 2023. doi:10.48797/sl.2023.29
BibTeX
@article{Sousa2023,
author = {Sousa and D. and Amaro and F. and Araújo and M., A. and Carvalho and M.},
title = {Impact of cannabidiol on viability of normal and tumorigenic human kidney cells: are the effects serum-dependent?},
journal = {Science Letters},
year = {2023},
doi = {10.48797/sl.2023.29}
}
EUVIMED